Jianfeng Zhou

InstitutionHuaZhong University of Science and Technology
AddressWuhan
Hubei
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 10 Covid-19 publications, with a maximum of 2 publications in July 2020
    All Publications
    Bar chart showing 234 publications over 20 distinct years, with a maximum of 25 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yang B, Fan J, Huang J, Guo E, Fu Y, Liu S, Xiao R, Liu C, Lu F, Qin T, He C, Wang Z, Qin X, Hu D, You L, Li X, Wang T, Wu P, Chen G, Zhou J, Li K, Sun C. Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection. Nat Commun. 2021 06 09; 12(1):3501. PMID: 34108465.
      Citations: 2     Fields:    Translation:HumansCells
    2. Luo H, Liu D, Liu W, Wang G, Chen L, Cao Y, Wei J, Xiao M, Liu X, Huang G, Wang W, Zhou J, Wang QF. Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms. Eur J Hum Genet. 2021 08; 29(8):1312-1315. PMID: 33867526.
      Citations: 5     Fields:    Translation:Humans
    3. Xie X, Cheng X, Wang G, Zhang B, Liu M, Chen L, Cheng H, Hao S, Zhou J, Zhu P, Cheng T. Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19. Sci China Life Sci. 2021 10; 64(10):1634-1644. PMID: 33564978.
      Citations:    Fields:    Translation:HumansCells
    4. Chen L, Wang G, Tan J, Cao Y, Long X, Luo H, Tang Q, Jiang T, Wang W, Zhou J. Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality. Signal Transduct Target Ther. 2020 12 14; 5(1):292. PMID: 33318472.
      Citations: 6     Translation:Humans
    5. Chen L, Wang G, Long X, Hou H, Wei J, Cao Y, Tan J, Liu W, Huang L, Meng F, Huang L, Wang N, Zhao J, Huang G, Sun Z, Wang W, Zhou J. Dynamics of Blood Viral Load Is Strongly Associated with Clinical Outcomes in Coronavirus Disease 2019 (COVID-19) Patients: A Prospective Cohort Study. J Mol Diagn. 2021 Jan; 23(1):10-18. PMID: 33122141.
      Citations: 10     Fields:    Translation:Humans
    6. Cao Y, Wei J, Wang G, Chen L, Luo H, Zhou J. Reply. J Allergy Clin Immunol. 2020 12; 146(6):1453-1454. PMID: 32980158.
      Citations: 1     Fields:    Translation:Humans
    7. Zhou X, Wang G, Chen L, Meng F, Huang L, Huang L, Wang N, Li T, Cao Y, Zhou J. Clinical characteristics of hematological patients concomitant with COVID-19. Cancer Sci. 2020 Sep; 111(9):3379-3385. PMID: 32619034.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    8. Chen L, Long X, Xu Q, Tan J, Wang G, Cao Y, Wei J, Luo H, Zhu H, Huang L, Meng F, Huang L, Wang N, Zhou X, Zhao L, Chen X, Mao Z, Chen C, Li Z, Sun Z, Zhao J, Wang D, Huang G, Wang W, Zhou J. Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients. Cell Mol Immunol. 2020 09; 17(9):992-994. PMID: 32620787.
      Citations: 61     Fields:    Translation:HumansCellsPHPublic Health
    9. Hu Y, Tan Su Yin E, Yang Y, Wu H, Wei G, Su J, Cui Q, Jin A, Yang L, Fu S, Zhou J, Qiu L, Zhang X, Liang A, Jing H, Li Y, Blaise D, Mohty M, Nagler A, Huang H. CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges. Curr Res Transl Med. 2020 08; 68(3):111-118. PMID: 32620465.
      Citations: 13     Translation:HumansCellsPHPublic Health
    10. Cao Y, Wei J, Zou L, Jiang T, Wang G, Chen L, Huang L, Meng F, Huang L, Wang N, Zhou X, Luo H, Mao Z, Chen X, Xie J, Liu J, Cheng H, Zhao J, Huang G, Wang W, Zhou J. Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol. 2020 Jul; 146(1):137-146.e3. PMID: 32470486.
      Citations: 133     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials